“`html
Key Points
-
Added 304,281 shares in AbbVie; estimated transaction value of $61.96 million
-
Post-trade stake: 2,324,286 shares valued at $538.17 million as of September 30, 2025
-
AbbVie now accounts for 2.01% of Los Angeles Capital Management LLC’s 13F assets
Los Angeles Capital Management LLC increased its position in AbbVie (NYSE: ABBV) by 304,281 shares during Q3 2025, with an estimated trade value of $61.96 million, according to its SEC filing on October 20, 2025. Following this purchase, the firm holds a total of 2,324,286 shares valued at approximately $538.17 million as of September 30, 2025.
As of October 20, 2025, AbbVie shares were priced at $232.06, reflecting a 24.4% increase over the year, outperforming the S&P 500 by 12.07 percentage points during the same period.
“`
